Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers W > Headlines for WakeMed > News item |
WakeMed, N.C., plans $295.77 million sale of revenue refunding bonds
By Sheri Kasprzak
New York, June 14 - The North Carolina Medical Care Commission is set to price $295,765,000 of series 2012 health care facilities revenue refunding bonds for WakeMed Corp., according to a preliminary official statement.
The bonds (A1//AA-) will be sold through senior manager Citigroup Global Markets Inc. The co-managers are BB&T Capital Markets, Wells Fargo Securities LLC and Edward D. Jones & Co. LP.
The maturity dates have not been set.
Proceeds will be used to refund WakeMed's series 2001 and series 2009A revenue bonds.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.